Loestrin Buyers Seek Approval Of $1M Lupin Deal
Loestrin end payors on Monday moved for preliminary approval of their $1 million settlement with Lupin Pharmaceuticals to resolve their portion of litigation accusing the company of working with another pharmaceutical...To view the full article, register now.
Already a subscriber? Click here to view full article